Tower Research Capital LLC (Trc) Lipocine Inc. Transaction History

Tower Research Capital LLC (Trc)

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.3 - $0.58 $2,168 - $4,192	7,228 Added 36.98%	26,772 $9,000
Q4 2022 Feb 10, 2023	BUY	$0.37 - $8.65 $3,569 - $83,446	9,647 Added 97.47%	19,544 $8,000
Q3 2022 Nov 10, 2022	BUY	$0.49 - $7.65 $4,849 - $75,712	9,897 New	9,897 $4,000
Q2 2022 Aug 15, 2022	SELL	$0.73 - $1.34 $6,244 - $11,462	-8,554 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.89 - $1.85 $5,335 - $11,090	5,995 Added 234.27%	8,554 $12,000
Q4 2021 Feb 14, 2022	SELL	$0.99 - $1.2 $4,958 - $6,010	-5,009 Reduced 66.19%	2,559 $3,000
Q3 2021 Nov 15, 2021	BUY	$1.08 - $1.49 $8,173 - $11,276	7,568 New	7,568 $8,000
Q3 2020 Nov 16, 2020	SELL	$1.21 - $2.23 $24,965 - $46,011	-20,633 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$0.42 - $1.26 $8,665 - $25,997	20,633 New	20,633 $26,000
Q4 2019 Feb 07, 2020	SELL	$0.32 - $3.15 $18 - $179	-57 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$1.79 - $3.33 $3,438 - $6,396	-1,921 Reduced 97.12%	57 $0
Q2 2019 Aug 13, 2019	BUY	$1.43 - $2.32 $2,828 - $4,588	1,978 New	1,978 $4,000
Q1 2018 May 15, 2018	SELL	$1.18 - $3.46 $1,257 - $3,688	-1,066 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$3.36 - $4.35 $3,134 - $4,058	-933 Reduced 46.67%	1,066 $4,000
Q3 2017 Nov 14, 2017	BUY	$3.67 - $4.19 $7,336 - $8,375	1,999	1,999 $8,000

Ticker LPCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,510,800
Market Cap $335M
Description
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.